Reclassification of marijuana opens doors for much-needed medical research … – The Conversation
The DEA's proposed reclassification of cannabis from Schedule I to Schedule III represents a watershed moment for medical research opportunities in cannabis medicine. This regulatory shift will remove decades-old barriers to rigorous clinical studies…
Feds decriminalize medical marijuana | Hawaii News Now
Federal medical marijuana decriminalization clinical impact extends beyond legal changes to fundamentally alter research opportunities and patient access. This policy shift removes Schedule I barriers that have limited evidence generation and therapeutic…
Marijuana research may reach new heights as Trump Administration reclassifies medical cannabis
The potential reclassification of cannabis to Schedule III could revolutionize medical research by removing decades-old barriers to rigorous clinical studies. This cannabis schedule III reclassification research impact represents a historic opportunity…
Reclassifying marijuana as a less dangerous drug might only be the first step for Trump
Federal cannabis reclassification to Schedule III represents a landmark shift in medical cannabis policy with significant clinical implications. This regulatory change acknowledges cannabis's therapeutic potential while creating new pathways for research…
In the Mix: 8 More Articles — May 08, 2026
In the Mix — Last 24 HoursMay 08, 2026. 8 articles reviewed below the CED clinical relevance threshold of 35. Listed in descending order of score. #25Bill to create psychedelic therapy program in Louisiana passes unanimously, heads to governorLouisiana…
Does Cannabis Legalization Spur More Innovation Than Medical Research?
✦ New CED Clinical Relevance #76Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic RegulationClinical ResearchProduct…
Trump DOJ Deregulates Marijuana to the Dismay of Health Experts – The Washington Stand
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PolicyMedical CannabisFederal…
US Department of Justice proposes marijuana reclassification, potential shift in federal stance
✦ New CED Clinical Relevance #82High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic PolicyFederal RegulationMedical…
Marijuana reclassification means big changes for Oklahoma businesses – The Oklahoman
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Federal PolicyMedical CannabisClinical…
The “entourage effect” isn’t bro science, minor cannabinoids and terpenes physically bind to …
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Entourage EffectCannabinoid…